Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Russell Inv US Small Cap Equity A RLACX
- NAV / 1-Day Return 27.64 / +0.44 %
- Total Assets 913.0 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.380%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 0.25%
- Turnover 80%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 11:06 PM GMT+0
Morningstar’s Analysis RLACX
Will RLACX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 8.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
E-mini Russell 2000 Index Future Mar 24 | 3.50 | 31.9 Mil | — |
U.S. Cash Management Fund | 3.16 | 28.7 Mil | Cash and Equivalents |
LeMaitre Vascular Inc | 0.72 | 6.5 Mil | Healthcare |
Viking Therapeutics Inc | 0.65 | 5.9 Mil | Healthcare |
Super Micro Computer Inc | 0.56 | 5.1 Mil | Technology |
Aris Water Solutions Inc Class A | 0.55 | 5.0 Mil | Utilities |
Rocket Pharmaceuticals Inc | 0.54 | 4.9 Mil | Healthcare |
UFP Technologies Inc | 0.52 | 4.7 Mil | Healthcare |
Netstreit Corp Ordinary Shares | 0.51 | 4.7 Mil | Real Estate |
e.l.f. Beauty Inc | 0.49 | 4.4 Mil | Consumer Defensive |